Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Financing Activities (2023 - 2025)

Fractyl Health's Cash from Financing Activities history spans 3 years, with the latest figure at $25.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 37544.78% year-over-year to $25.2 million, compared with a TTM value of $105.0 million through Dec 2025, up 3.69%, and an annual FY2025 reading of $105.0 million, up 3.69% over the prior year.
  • Cash from Financing Activities for Q4 2025 was $25.2 million at Fractyl Health, down from $78.1 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $101.0 million in Q1 2024, with the low at -$556000.0 in Q4 2023.
  • Average Cash from Financing Activities over 3 years is $19.5 million, with a median of $166500.0 recorded in 2024.
  • Biggest YoY gain for Cash from Financing Activities was 5050200.0% in 2024; the steepest drop was 117.86% in 2024.
  • Tracing GUTS's Cash from Financing Activities over 3 years: stood at -$556000.0 in 2023, then soared by 112.05% to $67000.0 in 2024, then soared by 37544.78% to $25.2 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Cash from Financing Activities are $25.2 million (Q4 2025), $78.1 million (Q3 2025), and $1.5 million (Q2 2025).